Metraipolis › archive › dc_57ef90359abd

Metformin Sensitizes PTEN-deficient Prostate Cancer to PARP Inhibitors by Rebuilding NADP+ Homeostasis — Europe PMC PMID:41608616

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41608616
DOI
10.7150/ijbs.121033
License (as archived)
solo-consultazione
Archived
2026-11-06T23:49:34.086Z
SHA-256 of the archived text
4365f3ac92e0083803029d58982c00cd13e8a4bc25cca46ab6c56e2a111091e3
Stable URL of this page
https://metraipolis.com/documento/dc_57ef90359abd

How to cite

Metformin Sensitizes PTEN-deficient Prostate Cancer to PARP Inhibitors by Rebuilding NADP+ Homeostasis — Europe PMC PMID:41608616 — Europe PMC (en), https://europepmc.org/article/MED/41608616 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_57ef90359abd (Metraipolis archive dc_57ef90359abd, sha256 4365f3ac92e0083803029d58982c00cd13e8a4bc25cca46ab6c56e2a111091e3)
BibTeX
@misc{dc57ef90359abd,
  title = {Metformin Sensitizes PTEN-deficient Prostate Cancer to PARP Inhibitors by Rebuilding NADP+ Homeostasis — Europe PMC PMID:41608616},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41608616},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_57ef90359abd; sha256 4365f3ac92e0083803029d58982c00cd13e8a4bc25cca46ab6c56e2a111091e3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41608616. Agents can read the archived copy with the MCP tool read_document.